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 The Life Sciences Initiative is an economic development initiative. If 
Kansas City is to prosper in the future, it has to address the infrastructure 
requirements of the 21st Century.  Today, economies are regional and if a 
region does not posses a significant "technology" infrastructure within the 
next five to ten years, it will not be in a position to compete.  The Kansas 
City Area Development Council and the Civic Council of Greater Kansas 
City established a Life Sciences Task Force which determined that the 
Life Sciences could provide this region with a competitive edge.  A 
tectonic shift has occurred in the world economy.  Strong arms and legs, a 
good work ethic, a central location, a low cost business climate, and 
access to materials and transportation will no longer be sufficient for a 
region to compete.  Rather, competitive advantage will be defined by a 
combination of traditional factors that equate to financial capital, and non-
traditional factors∇expertise and knowledge∇that equate to intellectual 
capital.  The regions that succeed in balancing this new equation will 
prosper into the future by expanding their economies and creating new 
value, wealth, capital, and profit through marketing products of the mind. 
 
 The Life Sciences Task Force determined that in order to attain its 
vision of Kansas City as "A nationally known center of established, world-
class life sciences companies, private and academic research institutions, 
and emerging, entrepreneurial companies in a community recognized for 
its opportunity and attractive quality of life," the community will have to do 
the following: 
 
¾ Make a major financial investment in Kansas City's institutions 
of higher education. 
 
¾ Build the physical and organizational support structure for life 
sciences entrepreneurs. 
 
¾ Develop, finance, and commercialize intellectual products in 
Kansas City. 
 
¾ Attract the brightest scientific talent and the best, young 
entrepreneurial companies that can be found. 
 
This past Spring the sponsoring organizations created the Life 
Sciences Institute and assigned it the following functions: 
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¾ Accountability 
¾ Evaluation 
¾ Oversight 
¾ Resource Allocation 
¾ Collaboration 
¾ Fundraising 
¾ Lobbying 
¾ Marketing 
 
The first order of business was to develop a business plan, which 
will be completed by the end of August.  This plan is concentrated around 
the following focus areas: 
 
¾ Human Development and Aging 
¾ Cancer 
¾ Cardiovascular Diseases 
¾ Neurological Diseases 
¾ Infectious Diseases 
 
Plans for commercialization, economic development, and 
educational support will be included.  Our goal is to develop a ten-year 
investment strategy that will enable the Area's research institutions to 
collectively attain $500 million annually in Research and Development 
expenditures. 
 
 How do we determine Kansas City's niche?  The competition is 
considerable and we will not be able to compete in every field.  In order to 
make the best possible investment decisions, we are employing the 
following:  an external Scientific Advisory Committee and a process called 
"business dynamics modeling."  The Committee will advise us on the 
science and where they believe we can be competitive.  The business 
dynamics modeling will show us what it will take to achieve the goal of 
$500 million in annual R & D expenditures. 
 
 The business plan will be presented to the boards of directors of 
the Kansas City Area Development Council and the Civic Council of 
Greater Kansas City for approval on September 8, 2000.  Fund raising will 
begin shortly thereafter. 
